Nanoceria-mediated delivery of doxorubicin enhances the anti-tumour efficiency in ovarian cancer cells via apoptosis

Nanocarriers are widely used for effective delivery of anticancer drugs to tumours with potential to improve cancer treatment. Here, we developed a nanoceria (CeO(2))-based system for delivery of the anti-cancer drug doxorubicin (DOX) to human ovarian cancer cells. Negatively charged nanoceria could...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Joydeep, Choi, Yun-Jung, Han, Jae Woong, Reza, Abu Musa Md Talimur, Kim, Jin-Hoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572723/
https://www.ncbi.nlm.nih.gov/pubmed/28842609
http://dx.doi.org/10.1038/s41598-017-09876-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572723/
https://www.ncbi.nlm.nih.gov/pubmed/28842609
http://dx.doi.org/10.1038/s41598-017-09876-w

Ejemplares similares